Global Ophthalmic Viscosurgical Devices Market Outlook, 2025 - Increasing Number of Cataract and Glaucoma Surgeries Performed


Dublin, Aug. 05, 2020 (GLOBE NEWSWIRE) -- The "Ophthalmic Viscosurgical Devices Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

The Global Ophthalmic Viscosurgical Devices Market is expected to register a CAGR of 4.5% during the forecast period.

This is attributing to the rapidly increasing geriatric population, increasing prevalence of diabetes, increasing number of cataract and glaucoma surgeries performed. The increasing geriatric population worldwide is more prone to ocular disorders.

These ophthalmic viscosurgical devices help in maintaining the anterior chamber during the surgical maneuver and are widely used as surgical aid for performing cataract, glaucoma and vitrectomy surgeries. For instance, as per the report published in the National Institute Center for Biotechnology said that in Germany around 800,000 people are going for cataract surgery every year.

Moreover, technological advancements, growing patient awareness, and preference about minimally invasive or noninvasive coupled with novel products are some more factors triggering the growth of the market. However, the availability of alternative procedures may hamper the market.

Key Market Trends

Ophthalmic Viscosurgical Devices in Cataract Surgery is Estimated to Witness Healthy Growth

Ophthalmic viscosurgical devices in cataract surgery are estimated to witness healthy growth in the future attributed to an increasing number of targeted patient pools, and growing awareness about ocular diseases. As these devices help in anterior chamber space maintenance and preventing corneal endothelial cell loss during ocular surgical procedures. This device thus results in improving surgical procedures. In addition to that decreased intraoperative surgical complication associated with using the device and technological advancements results in better and successful surgical outcomes. As per Eurostat, in 2017 around 5 million cataract surgeries were performed in Europe. With such a high number of surgeries performing results in the adoption of these devices ophthalmic viscosurgical devices due to several benefits associated with this device and further propel the segment growth.

North America Expected to Hold a Significant Share Over the Forecast Period

North America is expected to hold a significant market share in the global Ophthalmic Viscosurgical Devices Market due to the increasing aging population, improved access to ophthalmic care facilities, increasing healthcare expenditure and the presence of well-established healthcare infrastructure. Moreover, with the high number of cataract surgery population results in boosting the market in this region. For instance, as per the American Academy of Ophthalmology, it is estimated that around 50 million people suffer from cataracts in the United State which is also a leading cause of blindness in this region. Hence the rising number of the target populations in this region is expected to drive the market.

Competitive Landscape

The Ophthalmic Viscosurgical Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Rayner Intraocular Lenses Limited, Alcon AG, Beaver-Visitec International, Inc., Bohus Biotech AB, Truviz Ophthalmic, and Amring pharmaceutical Inc.

Key Topics Covered

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapidly Increasing Geriatric Population
4.2.2 Increasing Prevalence of Diabetes
4.2.3 Increasing Number of Cataract and Glaucoma Surgeries Performed
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Procedures
4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Cohesive
5.1.2 Dispersive
5.1.3 Viscoadaptive
5.2 By Source
5.2.1 Biological
5.2.2 Animal
5.2.3 Semi-synthetic
5.3 By Application
5.3.1 Glaucoma Surgery
5.3.2 Cataract Surgery
5.3.3 Corneal Grafting
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Johnson & Johnson
6.1.2 Carl Zeiss Meditec AG
6.1.3 Bausch & Lomb Incorporated
6.1.4 Rayner Intraocular Lenses Limited
6.1.5 Alcon AG
6.1.6 Beaver-Visitec International, Inc.
6.1.7 Bohus Biotech AB
6.1.8 Truviz Ophthalmic
6.1.9 Amring Pharmaceutical Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/prryrq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

 

Contact Data